269 related articles for article (PubMed ID: 32314274)
1. Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women.
Wu C; Yang W; Wu X; Zhang T; Zhao Y; Ren W; Xia J
Virol Sin; 2020 Jun; 35(3):305-310. PubMed ID: 32314274
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Outcomes of Childbearing-Age Women With COVID-19 in Wuhan: Retrospective, Single-Center Study.
Wei L; Gao X; Chen S; Zeng W; Wu J; Lin X; Zhang H; Mwamaka Sharifu L; Chen L; Feng L; Wang S
J Med Internet Res; 2020 Aug; 22(8):e19642. PubMed ID: 32750000
[TBL] [Abstract][Full Text] [Related]
4. Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2.
Mohr-Sasson A; Chayo J; Bart Y; Meyer R; Sivan E; Mazaki-Tovi S; Yinon Y
Arch Gynecol Obstet; 2020 Sep; 302(3):629-634. PubMed ID: 32572616
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of 16 patients with fecal severe acute respiratory syndrome coronavirus 2 nucleic acid-positive.
Zhou Y; Xiao Z; Chen D; Guan J; Zhou Z; Zhang H; Zhou H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):560-564. PubMed ID: 32879107
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
[TBL] [Abstract][Full Text] [Related]
7. Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia.
Han R; Huang L; Jiang H; Dong J; Peng H; Zhang D
AJR Am J Roentgenol; 2020 Aug; 215(2):338-343. PubMed ID: 32181672
[No Abstract] [Full Text] [Related]
8. Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients - a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China.
Zhu C; Yu S; Zhao H; Shen H; Yang J; Zhao L; Wu W
Clin Chem Lab Med; 2020 Aug; 58(9):e167-e170. PubMed ID: 32609644
[No Abstract] [Full Text] [Related]
9. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
[TBL] [Abstract][Full Text] [Related]
10. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
[TBL] [Abstract][Full Text] [Related]
11. Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Infection on Pregnant Women and Their Infants.
Yang H; Hu B; Zhan S; Yang LY; Xiong G
Arch Pathol Lab Med; 2020 Oct; 144(10):1217-1222. PubMed ID: 32422078
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of 71 patients with coronavirus disease 2019.
Xiao M; Hou M; Liu X; Li Z; Zhao Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 45(7):790-796. PubMed ID: 32879082
[TBL] [Abstract][Full Text] [Related]
13. Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence.
Ren HW; Wu Y; Dong JH; An WM; Yan T; Liu Y; Liu CC
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8210-8218. PubMed ID: 32767351
[TBL] [Abstract][Full Text] [Related]
14. Early Insights into Immune Responses during COVID-19.
St John AL; Rathore APS
J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850
[TBL] [Abstract][Full Text] [Related]
15. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
Yang M; Chen X; Xu Y
Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus.
Zhou Y; Zhang Z; Tian J; Xiong S
Ann Palliat Med; 2020 Mar; 9(2):428-436. PubMed ID: 32233642
[TBL] [Abstract][Full Text] [Related]
18. Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China.
Zhang L; Dong L; Ming L; Wei M; Li J; Hu R; Yang J
BMC Pregnancy Childbirth; 2020 Jul; 20(1):394. PubMed ID: 32641013
[TBL] [Abstract][Full Text] [Related]
19. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
[TBL] [Abstract][Full Text] [Related]
20. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
